Aspirin Tributes : Professor Ruth Langley
Aspirin Tributes Professor Ruth Langley has a particular interest in drug repurposing and is chief investigator of the Add-Aspirin trial. In this edition, Ruth discusses her inspiration and interest in aspirin, the role aspirin plays in cancer, as well as secondary and primary prevention. Read the full conversation here.
Aspirin Tributes : Professor Bianca Rocca
Aspirin Tributes Professor Bianca Rocca motivated by platelets and aspirin throughout her career. Bianca gives her views on the limitations of the ARRIVE & ASPREE trials; and discusses the future of personalised medicine and precision dosing. Read the full conversation here.
Aspirin Tributes : Professor Gemma Vilahur
Aspirin Tributes Professor Gemma Vilahur discusses her aspirin heroine, the role aspirin plays in the primary prevention of CVD, why aspirin is beneficial in patients with DM and the studies she has undertaken in that area, as well as why she is such a big aspirin fan. Read the full conversation here.
Aspirin Tributes : Dr Luis A. Garcia Rodriguez
Aspirin Tributes Dr Luis A Garcia Rodriguez explains why he is such a big aspirin fan To my mind the low cost of aspirin together with its favourable risk/ benefit profile helps to deliver a bigger bang for the buck than almost any other drug. Because aspirin is off patent taking it every day costs […]
The International Aspirin Foundation presents Dr Tracey Simon with the prestigious Emerging Aspirin Investigator Science Award for her seminal work linking aspirin with hepatocellular cancer prevention.
The International Aspirin Foundation presents Dr Tracey Simon with the prestigious Emerging Aspirin Investigator Science Award for her seminal work linking aspirin with hepatocellular cancer prevention. The International Aspirin Foundation (IAF)’s Science Award for the Emerging Aspirin Investigator recognises junior scientists in the early stages of their research career. The award aims to acknowledge and […]
The International Aspirin Foundation expands its Scientific Advisory Board by appointing world leading neurologist Professor Pierre Amarenco
The International Aspirin Foundation expands its Scientific Advisory Board by appointing world leading neurologist Professor Pierre Amarenco The International Aspirin Foundation is delighted and honoured to welcome internationally renowned neurologist, Professor Pierre Amarenco, to its Scientific Advisory Board. Professor Amarenco is Professor of Neurology at Paris University and Chairman of the Department of Neurology and […]
Are US cardiologists ADAPTABLE to considering low-dose aspirin for secondary prevention?
Giovanna Liuzzo and Carlo Patrono Department of Cardiovascular and Pulmonary Sciences, Fondazione Policlinico Gemelli-IRCCS, Catholic University School of Medicine, Largo A. Gemelli 8, 00168, Rome, Italy; and Department of Pharmacology, Fondazione Policlinico Gemelli-IRCCS, Catholic University School of Medicine, Largo F. Vito 1, 00168, Rome, Italy The results of ‘Comparative Effectiveness of Aspirin Dosing in Cardiovascular […]
IAF to present first symposium at the Oriental Congress of Cardiology (OCC)
The International Aspirin Foundation (IAF) will present its first ever symposium in China, at the 2021 Oriental Congress of Cardiology (OCC). The OCC conference, themed ‘Open, creative, co-operative’ will be held at the Shanghai International Convention Centre from 27 to 30 May 2021, and the IAF symposium will take place from 1pm to 5pm on […]
ASCO highlight aspirin’s role in reducing hereditary cancer risk.
The American Society of Clinical Oncology (ASCO), in their 16th Annual Report on Progress Against Cancer – Clinical Cancer Advances 2021, highlight the preventative role of aspirin in reducing cancer risk for people with a hereditary cancer predisposition. The report explains the massively increased cancer risk experienced by those with the hereditary condition Lynch syndrome. […]
Senior Science Award – full report now available
Professors Tom Meade, Jan van Gijn, Bo Norrving and Lars Wallentin, the scientists whose work established low-dose aspirin as a mainstay of antithrombotic therapy in the treatment and prevention of heart attack and stroke. Download the full report here
